Home/Filings/4/0001179110-12-005195
4//SEC Filing

EBERT CHARLES D 4

Accession 0001179110-12-005195

CIK 0000884629other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 2:17 PM ET

Size

4.6 KB

Accession

0001179110-12-005195

Insider Transaction Report

Form 4
Period: 2012-03-14
EBERT CHARLES D
Sr. VP, Research & Development
Transactions
  • Tax Payment

    Common Stock, par value $0.0033

    2012-03-14$59.21/sh1,265$74,90126,926 total
Footnotes (1)
  • [F1]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.

Issuer

WATSON PHARMACEUTICALS INC

CIK 0000884629

Entity typeother

Related Parties

1
  • filerCIK 0001241752

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 2:17 PM ET
Size
4.6 KB